CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CALC CALCIMEDICA

Market Closed 05-17 16:00:00 EDT

5.45

+0.02

+0.37%

盘后5.45

+0.000.00%

16:00 EDT

High5.90	Low5.45	Vol55.93K
Open5.51	D1 Closing5.43	Amplitude8.29%
Mkt Cap58.53M	Tradable Cap24.79M	Total Shares10.74M
T/O314.17K	T/O Rate1.23%	Tradable Shares4.55M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":5.45,"timestamp":1715976000000,"preClose":5.43,"halted":0,"volume":55926,"hourTrading":{"tag":"盘后","latestPrice":5.45,"preClose":5.45,"latestTime":"16:00 EDT","volume":213,"amount":1160.8500000000001,"timestamp":1715976001828},"delay":0,"floatShares":4548084,"shares":10740115,"eps":-2.22827,"marketStatus":"Market Closed","change":0.02,"latestTime":"05-17 16:00:00 EDT","open":5.51,"high":5.9,"low":5.45,"amount":314171.3946,"amplitude":0.082873,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.22827,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1716192000000},"marketStatusCode":7,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":5.43,"preHourTrading":{"tag":"盘前","latestPrice":5.62,"preClose":5.44,"latestTime":"08:53 EDT","volume":15,"amount":84.3,"timestamp":1715950383234},"postHourTrading":{"tag":"盘后","latestPrice":5.45,"preClose":5.45,"latestTime":"16:00 EDT","volume":213,"amount":1160.8500000000001,"timestamp":1715976001828},"volumeRatio":3.7381690468862847},"requestUrl":"/m/hq/s/CALC/tweets","defaultTab":"tweets","newsList":[{"id":"2435585517","title":"CalciMedica GAAP EPS of $0.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2435585517","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435585517?lang=en_us&edition=fundamental","pubTime":"2024-05-14 22:52","pubTimestamp":1715698323,"startTime":"0","endTime":"0","summary":"CalciMedica press release  (NASDAQ:CALC): Q1  GAAP EPS of $0.01.\nCash position expected to fund operations into 2H 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4105900-calcimedica-gaap-eps-of-0_01","is_publish_highlight":false,"gpt_icon":0},{"id":"2435583593","title":"CalciMedica Inc reports results for the quarter ended in January - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2435583593","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2435583593?lang=en_us&edition=fundamental","pubTime":"2024-05-14 05:25","pubTimestamp":1715635550,"startTime":"0","endTime":"0","summary":"* CalciMedica Inc    reported quarterly adjusted earnings of 1 cent per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of $-23.43.  The m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435130203","title":"CalciMedica Q1 2024 GAAP EPS $0.01 Beats $(0.67) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2435130203","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2435130203?lang=en_us&edition=fundamental","pubTime":"2024-05-14 04:19","pubTimestamp":1715631559,"startTime":"0","endTime":"0","summary":"CalciMedica (NASDAQ:CALC) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.67) by 101.49 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38800913/calcimedica-q1-2024-gaap-eps-0-01-beats-0-67-estimate","is_publish_highlight":false,"gpt_icon":0},{"id":"2435227347","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2435227347","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2435227347?lang=en_us&edition=fundamental","pubTime":"2024-05-13 18:00","pubTimestamp":1715594400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":1},{"id":"2434691418","title":"CalciMedica Inc    expected to post a loss of 67 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2434691418","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2434691418?lang=en_us&edition=fundamental","pubTime":"2024-05-11 00:31","pubTimestamp":1715358670,"startTime":"0","endTime":"0","summary":"* CalciMedica Inc     is expected to show no change in quarterly revenue when it reports  results on May 13 (estimated) for the period ending March 31 2024   *    * LSEG's mean analyst estimate for Ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2434836860","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2434836860","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2434836860?lang=en_us&edition=fundamental","pubTime":"2024-05-10 18:00","pubTimestamp":1715335200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.i3 Verticals Inc. Class A                       2Q       .38       BMO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2433206162","title":"CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2433206162","media":"PR Newswire","top":-1,"share":"https://ttm.financial/m/news/2433206162?lang=en_us&edition=fundamental","pubTime":"2024-05-07 20:00","pubTimestamp":1715083200,"startTime":"0","endTime":"0","summary":"Collaborators from Cedars-Sinai to present human proteomics data supporting the potential benefits of Auxora in severe acute pancreatitis . LAJOLLA, Calif., May 7, 2024 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced the acceptance of an abstract for poster presentation by a collaborator from Cedars-Sinai Medical Center at the upcoming Digestive Disease Week  2024 being held May 18-21 in Washington, DC and virtually.Presentation Title: Serum Proteomics Reveals That the Orai1 Inhibitor Auxora May Provide Benefits in Severe Acute Pancreatitis Similar to Those Seen in COVID-19 Pneumonia. Session Date and Time: Saturday, May 18, 12:30-1:30 p.m. ET","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-announces-upcoming-presentation-digestive-120000500.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-announces-upcoming-presentation-digestive-120000500.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430740468","title":"Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Acrivon Therapeutics, Inc. (ACRV) and Viking Therapeutics (VKTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2430740468","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2430740468?lang=en_us&edition=fundamental","pubTime":"2024-04-25 20:07","pubTimestamp":1714046874,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CalciMedica (CALC – Research Report), Acrivon Therap...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-calcimedica-calc-acrivon-therapeutics-inc-acrv-and-viking-therapeutics-vktx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-calcimedica-calc-acrivon-therapeutics-inc-acrv-and-viking-therapeutics-vktx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2429437703","title":"BRIEF-CalciMedica Announces Last Patient Enrolled In Phase 2B Carpo Trial Of Auxora","url":"https://stock-news.laohu8.com/highlight/detail?id=2429437703","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2429437703?lang=en_us&edition=fundamental","pubTime":"2024-04-24 20:07","pubTimestamp":1713960469,"startTime":"0","endTime":"0","summary":"April 24  - CalciMedica Inc   :   * CALCIMEDICA ANNOUNCES LAST PATIENT ENROLLED IN PHASE 2B CARPO TRIAL OF AUXORA IN ACUTE PANCREATITIS   * CALCIMEDICA INC: FULL TARGET ENROLLMENT OF 216 PATIENTS ACHIEVED   * CALCIMEDICA INC: TOPLINE DATA FROM CARPO EXPECTED IN 2Q 2024Source text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429437608","title":"CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2429437608","media":"PR Newswire","top":-1,"share":"https://ttm.financial/m/news/2429437608?lang=en_us&edition=fundamental","pubTime":"2024-04-24 20:00","pubTimestamp":1713960000,"startTime":"0","endTime":"0","summary":"LAJOLLA, Calif., April 24, 2024 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that the last patient has been enrolled in its Phase 2b CARPO trial of Auxora in acute pancreatitis . Auxora is a potent and selective small molecule inhibitor of Orai1-containing CRAC channels that is being developed for use in patients with acute inflammatory and immunologic illnesses.CARPO is an international, randomized, double-blind, placebo-controlled, dose-ranging trial intended to establish Auxora's dose-response and efficacy in AP with accompanying systemic inflammatory response syndrome . The trial reached its target enrollment of 216. These patients have been randomized into four groups to receive either 2.0 mg/kg, 1.0 mg/kg or 0.5 mg/kg of Auxora or a dose of placebo intravenously every 24 hours fo","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-announces-last-patient-enrolled-120000331.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-announces-last-patient-enrolled-120000331.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426536442","title":"Insiders are Piling into These 10 Healthcare Stocks in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2426536442","media":"Insider Monkey","top":-1,"share":"https://ttm.financial/m/news/2426536442?lang=en_us&edition=fundamental","pubTime":"2024-04-11 03:30","pubTimestamp":1712777442,"startTime":"0","endTime":"0","summary":"In this article, we will take a detailed look atInsiders are Piling into These 10 Healthcare Stocks in 2024.For a quick overview of such stocks, read our articleInsiders are Piling into These 5 Healthcare Stocks in 2024.Healthcare investors were nervous when 2024 started, since election years usually don’t bode well for healthcare stocks. But on the back of several growth catalysts, healthcare stocks have fared well so far in the year. As of March, the S&P 500 Healthcare had gained about 7.1% in the year, which was the best start since 2017, according to Dow Jones Market Data. While the sector has pared some of those gains since, it’s still up 4.1% year to date through April 9 as GLP-1 drugs for weight loss and diabetes continue to make headlines with new breakthrough results and developments.\"Obesity care sales grew 154%. In International operations, sales grew 47%, driven by both Saxenda and Wegovy. Sales of Saxenda increased by 14% and sales","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/yhew4P7J4EDov_lGOlGEig--~B/aD04NTU7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/6bb1d8eb85b54c6b741ba52e7feefdcd","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/yhew4P7J4EDov_lGOlGEig--~B/aD04NTU7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/6bb1d8eb85b54c6b741ba52e7feefdcd"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insiders-piling-10-healthcare-stocks-193042908.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424712603","title":"CalciMedica Is Maintained at Outperform by Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2424712603","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2424712603?lang=en_us&edition=fundamental","pubTime":"2024-04-01 21:26","pubTimestamp":1711977960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CALC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2024 09:26 ET (13:26 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2424233799","title":"Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Apollomics (APLM) and Iterum Therapeutics (ITRM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2424233799","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2424233799?lang=en_us&edition=fundamental","pubTime":"2024-04-01 18:30","pubTimestamp":1711967416,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CalciMedica (CALC – Research Report), Apollomics (AP...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-calcimedica-calc-apollomics-aplm-and-iterum-therapeutics-itrm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-calcimedica-calc-apollomics-aplm-and-iterum-therapeutics-itrm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2423462658","title":"BRIEF-Calcimedica Says May Offer, Sell Shares Of Common Stock Of Up To $17.1 Million From Time To Time Through Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2423462658","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2423462658?lang=en_us&edition=fundamental","pubTime":"2024-03-29 21:33","pubTimestamp":1711719233,"startTime":"0","endTime":"0","summary":"March 29 (Reuters) - CalciMedica Inc   :   * CALCIMEDICA INC - MAY OFFER, SELL SHARES OF COMMON STOCK OF UP TO $17.1 MILLION FROM TIME TO TIME THROUGH WAINWRIGHTSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2423244561","title":"Paul's bank promised to 'keep an eye' on his account while he invested in cryptocurrency. He still lost $480k","url":"https://stock-news.laohu8.com/highlight/detail?id=2423244561","media":"ABC News","top":-1,"share":"https://ttm.financial/m/news/2423244561?lang=en_us&edition=fundamental","pubTime":"2024-03-29 05:15","pubTimestamp":1711660533,"startTime":"0","endTime":"0","summary":"When Paul called ING with a question about his cryptocurrency investment, the bank's scam team was alerted. Now, after losing nearly $500,000 to a romance scam, Paul argues the bank could have stopped it.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"abcau_stock","url":"https://www.abc.net.au/news/2024-03-29/ing-macquarie-crypto-romance-scam/103640562","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.abc.net.au/news/2024-03-29/ing-macquarie-crypto-romance-scam/103640562","is_publish_highlight":false,"gpt_icon":0},{"id":"2423146669","title":"CalciMedica GAAP EPS of -$7.66 beats by $3.78","url":"https://stock-news.laohu8.com/highlight/detail?id=2423146669","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2423146669?lang=en_us&edition=fundamental","pubTime":"2024-03-29 01:40","pubTimestamp":1711647639,"startTime":"0","endTime":"0","summary":"CalciMedica press release  : FY  GAAP EPS of -$7.66  beats by $3.78.As of December 31, 2023, CalciMedica had $11.2 million in cash, cash equivalents and short-term investments.More on CalciMedica  CalciMedica to raise up to ~$55M Seeking Alpha’s Quant Rating on CalciMedica Historical earnings data for CalciMedica Financial information for CalciMedica","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4085092-calcimedica-gaap-eps-of-7_66-beats-3_78","is_publish_highlight":false,"gpt_icon":0},{"id":"2422195849","title":"CalciMedica Q4 EPS $(0.23)","url":"https://stock-news.laohu8.com/highlight/detail?id=2422195849","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2422195849?lang=en_us&edition=fundamental","pubTime":"2024-03-28 20:45","pubTimestamp":1711629937,"startTime":"0","endTime":"0","summary":"CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.23) per share.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/03/37981541/calcimedica-q4-eps-0-23","is_publish_highlight":false,"gpt_icon":0},{"id":"2422160094","title":"CalciMedica Inc reports results for the quarter ended in December - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2422160094","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2422160094?lang=en_us&edition=fundamental","pubTime":"2024-03-28 20:22","pubTimestamp":1711628541,"startTime":"0","endTime":"0","summary":"* CalciMedica Inc    reported a quarterly adjusted loss of 23 cents per share for the quarter ended in December.  The mean expectation of four analysts for the quarter was for a loss of 87 cents per s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422161704","title":"CalciMedica FY23 EPS $(7.66) Vs $(111.16) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2422161704","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2422161704?lang=en_us&edition=fundamental","pubTime":"2024-03-28 19:28","pubTimestamp":1711625332,"startTime":"0","endTime":"0","summary":"CalciMedica FY23 EPS $(7.66) Vs $(111.16) YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/03/37979250/calcimedica-fy23-eps-7-66-vs-111-16-yoy","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.calcimedica.com","stockEarnings":[{"period":"1week","weight":-0.0268},{"period":"1month","weight":0.2558},{"period":"3month","weight":0.2138},{"period":"6month","weight":0.9123},{"period":"1year","weight":1.0762},{"period":"ytd","weight":0.8601}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.425181},{"month":2,"riseRate":0,"avgChangeRate":-0.241659},{"month":3,"riseRate":0,"avgChangeRate":-0.299918},{"month":4,"riseRate":0.25,"avgChangeRate":-0.031156},{"month":5,"riseRate":0.25,"avgChangeRate":-0.059522},{"month":6,"riseRate":0.666667,"avgChangeRate":0.153249},{"month":7,"riseRate":0,"avgChangeRate":-0.157202},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.017026},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.079114},{"month":10,"riseRate":0.666667,"avgChangeRate":0.015449},{"month":11,"riseRate":0.25,"avgChangeRate":0.074217},{"month":12,"riseRate":0.5,"avgChangeRate":-0.082044}],"exchange":"NASDAQ","name":"CALCIMEDICA","nameEN":"CALCIMEDICA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CALCIMEDICA(CALC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CALCIMEDICA,CALC,CALCIMEDICA股票,CALCIMEDICA股票老虎,CALCIMEDICA股票老虎国际,CALCIMEDICA行情,CALCIMEDICA股票行情,CALCIMEDICA股价,CALCIMEDICA股市,CALCIMEDICA股票价格,CALCIMEDICA股票交易,CALCIMEDICA股票购买,CALCIMEDICA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CALCIMEDICA(CALC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}